OpenVSafe by OpenVAERS
Search V-safe

A92-30641-72044

4 vaccinations 14 coded responses 37 check-ins 15 free-text entries 2 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
222 / VA
Registered
2021-02-11
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-11
    Registered in v-safe
  2. 2021-02-11
    Dose 1 — Pfizer-BioNTech
  3. 2021-02-11
    Survey response — day 0, dose 1
    MedDRA: Gastrointestinal disorder, Hypoaesthesia, Peripheral coldness, Pre-existing disease — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Cold, numbness in feet (diabetic). Feel hot inside stomach, intestine. (Chronic Kidney Disease).
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-02-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-02-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache
    Adult check-in
  6. 2021-02-15
    Survey response — days 1–6 daily, dose 1
    MedDRA: Chronic kidney disease, Diabetes mellitus, Pre-existing disease — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Diabetic; chronic kidney disease.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-02-16
    Survey response — days 1–6 daily, dose 1
    MedDRA: Diabetes mellitus, Peripheral coldness, Pre-existing disease — Feeling: Good · Fatigue or tiredness
    Free text: Cold hands and feet. (Diabetic)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-02-17
    Survey response — days 1–6 daily, dose 1
    MedDRA: Feeling cold, Pre-existing disease — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Coldness all over. Diabetic.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-02-19
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-25
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-03-04
    Dose 2 — Pfizer-BioNTech
  12. 2021-03-04
    Survey response — day 0, dose 2
    MedDRA: Blood glucose increased, Diabetes mellitus — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Free text: Diabetic: elevated blood sugar.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-03-05
    Survey response — days 1–6 daily, dose 2
    MedDRA: Blood glucose increased, Diabetes mellitus, Pre-existing disease — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Diabetic: high blood sugar.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-03-06
    Survey response — days 1–6 daily, dose 2
    MedDRA: Pre-existing disease, Vision blurred — Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Diabetic, cataracts, glaucoma: increased blurred vision.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-03-07
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cataract, Diabetes mellitus, Glaucoma, Pre-existing disease, Vision blurred — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Diabetic, cataract, glaucoma: blurred vision.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-03-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  17. 2021-03-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  18. 2021-03-10
    Survey response — days 1–6 daily, dose 2
    MedDRA: Diabetes mellitus — Feeling: Fair · Site: Pain · Fatigue or tiredness
    Free text: Diabetic: elevated blood sugar.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-03-12
    Health check-in — day 7, dose 2
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Diabetic: elevated blood sugar.
    Adult check-in · check-in free text available
  20. 2021-03-19
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-25
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  22. 2021-04-01
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-04-08
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-15
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  25. 2021-06-05
    Survey response — 3 months, dose 2
    MedDRA: Cataract, Glaucoma, Office visit, Ophthalmological examination, Vision blurred, Visual impairment — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Mature Glaucoma and cataracts.More blurred, dark vision. · Healthcare visit (other): In office, comprehensive eye exam.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-06-05
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  27. 2021-09-05
    Survey response — 6 months, dose 2
    MedDRA: Cataract, Glaucoma, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Mature glaucoma and Cataracts. · Healthcare visit (other): Doctors Office: In person.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  28. 2021-09-05
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  29. 2021-09-07
  30. 2021-09-25
    Dose 3 — Pfizer-BioNTech
  31. 2021-10-03
    Health check-in — day 7, dose 3
    Feeling: Fair · None
    Adult check-in
  32. 2021-10-12
    Health check-in — day 14, dose 3
    Feeling: Fair
    Adult check-in
  33. 2021-10-16
    Survey response — day 21, dose 3
    MedDRA: Cataract, Glaucoma — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Severe Glaucoma and Senile Cataracts.
    MedDRA releases: 2024-11 · check-in free text available
  34. 2021-10-23
    Health check-in — day 28, dose 3
    Feeling: Fair
    Adult check-in
  35. 2021-10-30
    Health check-in — day 35, dose 3
    Feeling: Fair
    Adult check-in
  36. 2021-11-07
    Survey response — day 42, dose 3
    MedDRA: Abdominal pain upper, Asthenia, Fatigue, Frequent bowel movements, Pollakiuria — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Stomach pain. Frequent urge to urinate and bowel movement. Feeling tired and weak.
    MedDRA releases: 2024-11 · check-in free text available
  37. 2021-12-27
    Health check-in — 3 months, dose 3
    Feeling: Fair
    Adult check-in
  38. 2022-03-26
    Survey response — 6 months, dose 3
    MedDRA: Open angle glaucoma — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Advanced open angle glaucoma. Severe Stage.
    MedDRA releases: 2024-11 · check-in free text available
  39. 2022-04-19
    Dose 4 — Pfizer-BioNTech
  40. 2022-04-19
    Health check-in — day 0, dose 4
    Feeling: Fair · None
    Adult check-in
  41. 2022-04-20
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  42. 2022-04-22
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · None
    Adult check-in
  43. 2022-04-25
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · None
    Adult check-in
  44. 2022-05-03
    Health check-in — day 14, dose 4
    Feeling: Fair
    Adult check-in
  45. 2022-05-10
    Health check-in — day 21, dose 4
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-02-11Pfizer-BioNTech
22021-03-04Pfizer-BioNTech
32021-09-25Pfizer-BioNTech No
42022-04-19Pfizer-BioNTech No

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 4 — day 0, dose 1

2021-02-11

Systemic reaction (other): Cold, numbness in feet (diabetic). Feel hot inside stomach, intestine. (Chronic Kidney Disease).

Release 4 — days 1–6 daily, dose 1

2021-02-15

Systemic reaction (other): Diabetic; chronic kidney disease.

2021-02-16

Systemic reaction (other): Cold hands and feet. (Diabetic)

2021-02-17

Systemic reaction (other): Coldness all over. Diabetic.

Release 5 — day 0, dose 2

2021-03-04

Systemic reaction (other): Diabetic: elevated blood sugar.

Release 5 — days 1–6 daily, dose 2

2021-03-05

Systemic reaction (other): Diabetic: high blood sugar.

2021-03-06

Systemic reaction (other): Diabetic, cataracts, glaucoma: increased blurred vision.

2021-03-07

Systemic reaction (other): Diabetic, cataract, glaucoma: blurred vision.

2021-03-10

Systemic reaction (other): Diabetic: elevated blood sugar.

Release 8 — 3 months, dose 2

2021-06-05

Symptoms: Mature Glaucoma and cataracts.More blurred, dark vision.
Healthcare visit (other): In office, comprehensive eye exam.

Release 9 — 6 months, dose 2

2021-09-05

Symptoms: Mature glaucoma and Cataracts.
Healthcare visit (other): Doctors Office: In person.

Release 10 — day 21, dose 3

2021-10-16

Symptoms: Severe Glaucoma and Senile Cataracts.

Release 10 — day 42, dose 3

2021-11-07

Symptoms: Stomach pain. Frequent urge to urinate and bowel movement. Feeling tired and weak.

Release 11 — 6 months, dose 3

2022-03-26

Symptoms: Advanced open angle glaucoma. Severe Stage.

Release 12 — day 7, dose 2

2021-03-12

Systemic reaction (other): Diabetic: elevated blood sugar.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
HCVOOphthalmological examination ○ ✓ ○
SDAbdominal pain upper · · ✓
SDAsthenia · · ✓
SDCataract ✓ ✓ ✓
SDFatigue · · ✓
SDFrequent bowel movements · · ✓
SDGlaucoma ✓ ✓ ✓
SDOpen angle glaucoma · · ✓
SDPollakiuria · · ✓
SDVision blurred ✓ ✓ ✓
SDVisual impairment ✓ ✓ ✓
SROBlood glucose increased ✓ ✓ ✓
SROCataract ✓ ✓ ✓
SROChronic kidney disease ✓ ✓ ✓
SRODiabetes mellitus ✓ ✓ ✓
SROFeeling cold ✓ ✓ ✓
SROGastrointestinal disorder ✓ ✓ ✓
SROGlaucoma ✓ ✓ ✓
SROHypoaesthesia ✓ ✓ ✓
SRONasopharyngitis ○ ○ ○
SROPeripheral coldness ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROVision blurred ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release